Puluo Pharmaceuticals: The Phase III clinical trial of simocoglucagon project has been fully enrolled.

Puluo Pharmaceutical stated on the interactive platform that the company's Simelgutide project Phase III clinical trial has been fully enrolled and is currently undergoing follow-up visits.